SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-022744
Filing Date
2022-02-14
Accepted
2022-02-14 16:11:33
Documents
1
Group Members
VENROCK MANAGEMENT VII, LLCVENROCK PARTNERS VII, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G tm226174d2_sc13g.htm SC 13G 101991
  Complete submission text file 0001104659-22-022744.txt   103577
Mailing Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304
Business Address 3340 HILLVIEW AVENUE PALO ALTO CA 94304 650 475 3734
Venrock Associates VII, L.P. (Filed by) CIK: 0001614766 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Subject) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92616 | Film No.: 22631893
SIC: 2834 Pharmaceutical Preparations